Sara Ng: Moving Beyond Management to Stewardship – “Advancing Anticoagulation Stewardship” Released by NQF
Sara Ng, Clinical and Laboratory Haematologist, Director of Thrombosis and Haemostasis at South Western Sydney Local Health District, shared a post by Anticoagulation Forum on LinkedIn:
“Moving Beyond “Management” to “Stewardship”
Anticoagulants are life-saving, but they remain a top cause of adverse drug events. It’s time to upgrade our approach. The Joint Commission and the National Quality Forum (NQF) have released “Advancing Anticoagulation Stewardship: A Playbook.” This isn’t just about meeting National Patient Safety Goals — It is about building a resilient system that proactively prevents harm.
The 7 Core Elements of a Stewardship Program –
To truly protect our patients, we need to implement these foundational pillars:
1. Leadership Commitment: Securing resources (human, financial, tech) is the non-negotiable first step.
2. Accountability and Expertise: Appoint a single leader responsible for outcomes, supported by clinicians with deep hemostasis expertise.
3. Multidisciplinary Support: Break the silos. Pharmacy, Nursing, Hematology, and IT must work as one unit.
4. Data Tracking: You can’t fix what you don’t measure. Track performance, adverse events, and adherence to guidelines.
5. Systematic Care: Implement evidence-based protocols that are sustainable and standardized across the system.
6. Transitions of Care: The danger zone. Create robust safety nets for patients moving between hospital and home.
7. Education: Ensure every stakeholder—from the prescribing resident to the patient—understands the “why” and “how” of their therapy.
Why This Matters
We often focus on the drug (dosing, monitoring). Stewardship focuses on the system. By addressing barriers like limited data or fragmented communication, we can significantly reduce the risk of bleeding and thrombosis.”
Quoting Anticoagulation Forum‘s post:
“We are proud to have partnered with the National Quality Forum (NQF) on this important resource. It remains a valuable guide for organizations worldwide working to improve patient safety and implement evidence-based stewardship practices.
Explore the report here.”
More posts from Sara Ng on Hemostasis Today.
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics